Carrie Hess, DPM
Podiatrist · Tucson, AZNPI 1396915377
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Smith+Nephew at 41.6% of the total. 2025 is the largest year on record at $770, more than ten times the $68 reported in 2019.
Across 75 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$787
- Orthofix Medical, Inc.$189
- Medshape, Inc.$150
- Globus Medical$85
- Solventum Corporation$62
- Bioventus LLC$53
- plus $568 from 22 others
What the payments were for
- Food & beverage$1,894100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 28 | $787 |
| Orthofix Medical, Inc. | 11 | $189 |
| Medshape, Inc. | 1 | $150 |
| Globus Medical | 1 | $85 |
| Solventum Corporation | 2 | $62 |
| Bioventus LLC | 1 | $53 |
| Integra Lifesciences Corporation | 3 | $47 |
| Biowound Solutions, Inc. | 2 | $47 |
| Organogenesis Inc. | 3 | $45 |
| Bard Peripheral Vascular, Inc. | 1 | $44 |
| Amgen | 2 | $36 |
| International Rehabilitative Sciences, Inc | 1 | $35 |
| Merck | 2 | $32 |
| GRT US Holding, Inc. | 1 | $31 |
| Tactile Systems Technology Inc | 1 | $26 |
| IBSA Pharma Inc. | 2 | $26 |
| Abbott | 1 | $23 |
| Treace Medical Concepts, Inc. | 1 | $21 |
| Zimmer Biomet | 1 | $20 |
| Vertex | 1 | $18 |
| Acera Surgical, Inc. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $17 |
| Misonix Inc | 1 | $17 |
| Advanced Oxygen Therapy Inc. | 2 | $17 |
| Stryker | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
| Krystal Biotech Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,894 in reported general payments places this provider in the 70th percentile of 151 podiatrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 68 | $663 |
| Ketoconazole | 18 | $421 |
| Betamethasone Dipropionate | 11 | $378 |
| Gabapentin | 33 | $354 |
| Terbinafine Hcl | 17 | $320 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $213 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Tucson
- Barbara AungTucson$77K
- Amram DahukeyTucson$3K
- Alan ShihTucson$2K
- Steven HollanderTucson$2K
- Kris DinucciScottsdale$1.4M
- Lewis FreedMesa$997K
- Stephen KominskySun City West$508K
- Chad WestphalPeoria$300K
- Kerry ZangMesa$111K
- Todd HaddonMesa$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.